Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
Clinical trial NCT03362177 · COMPLETED
Trial details
- NCT number
- NCT03362177
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-30
- Primary completion
- 2024-01-25
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.